{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:29:00Z","timestamp":1789385340259,"version":"build-2803163510"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Microglia, the resident immune cells of the central nervous system, play a pivotal role in neuroinflammation and is a key contributor to the onset and progression of various neurological and neurodegenerative diseases. The Transient Receptor Potential Melastatin 2 (TRPM2), a non-selective calcium channel, has emerged as a sensor linking oxidative stress responses and calcium influx. It is expressed in many tissues and cells, including neurons, astrocytes, and microglia. TRPM2 represents one of the molecular mediators regulating microglial activity and function, cytokine production, and microglia-neuron communication. Growing evidence suggests that TRPM2 contributes to the pathological mechanisms underlying diseases such as ischemic stroke, Alzheimer\u2019s disease, Parkinson\u2019s disease, epilepsy, and neuropathic pain. However, most of the studies mainly explored the TRPM2 involvement in cell death, which has been reviewed by some other authors. In this review, we compile and discuss findings from in vivo and in vitro studies evaluating the role of TRPM2, with a specific focus on its influence over microglial function and neuroinflammatory responses, a field that has been poorly explored. We gathered information from studies reporting, in stroke models, that both pharmacological inhibition and genetic deletion of TRPM2 reduced infarct volume, improved behavioral outcomes, and diminished glial reactivity. In models of neurodegeneration, TRPM2 modulation shows promising effects on neuronal survival and microglial phenotype. In neuropathic pain models, TRPM2 was found to mediate microglial activation and the release of pro-inflammatory mediators, contributing to pain hypersensitivity. However, findings in epilepsy models reveal a more complex picture, with TRPM2 deficiency producing either neuroprotective or deleterious outcomes, highlighting the need for further studies. Although most studies to date support a pathogenic role for TRPM2 in microglia-mediated neuroinflammation, some limitations were highlighted, as the non-selective pharmacological inhibitors available, the inclusion of only males in the majority of studies, and the use of a global TRPM2 knockout. Only two studies employed conditional genetic models to promote specific TRPM2 deletion from microglia, with promising findings. Overall, current evidence indicates TRPM2 as a promising modulator of microglia, with broad implications for the treatment of neurological disorders characterized by chronic inflammation.<\/jats:p>","DOI":"10.1038\/s41401-026-01797-7","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T23:56:49Z","timestamp":1776902209000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Inhibiting the transient receptor potential melastatin 2 channel in microglia: current evidence and therapeutic potential in neurological disorders"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4096-9911","authenticated-orcid":false,"given":"Ana Fl\u00e1via F.","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2454-4462","authenticated-orcid":false,"given":"Zhong-Ping","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5142-1874","authenticated-orcid":false,"given":"Hong-Shuo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0563-0645","authenticated-orcid":false,"given":"Luiz Roberto G.","family":"Britto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"key":"1797_CR1","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"JD Steinmetz","year":"2024","unstructured":"Steinmetz JD, Seeher KM, Schiess N, Nichols E, Cao B, Servili C, et al. Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 2024;23:344\u201381.","journal-title":"Lancet Neurol"},{"key":"1797_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S1474-4422(19)30411-9","volume":"19","author":"VL Feigin","year":"2020","unstructured":"Feigin VL, Vos T, Nichols E, Owolabi MO, Carroll WM, Dichgans M, et al. The global burden of neurological disorders: translating evidence into policy. Lancet Neurol. 2020;19:255\u201365.","journal-title":"Lancet Neurol"},{"key":"1797_CR3","doi-asserted-by":"crossref","unstructured":"Skaper SD, Facci L, Zusso M, Giusti P. An inflammation-centric view of neurological disease: beyond the neuron. Front Cell Neurosci. 2018;12:72.","DOI":"10.3389\/fncel.2018.00072"},{"key":"1797_CR4","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2010.02.029","volume":"140","author":"C Nathan","year":"2010","unstructured":"Nathan C, Ding A. Nonresolving inflammation. Cell. 2010;140:871\u201382.","journal-title":"Cell"},{"key":"1797_CR5","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","volume":"110","author":"RC Paolicelli","year":"2022","unstructured":"Paolicelli RC, Sierra A, Stevens B, Tremblay ME, Aguzzi A, Ajami B, et al. Microglia states and nomenclature: a field at its crossroads. Neuron. 2022;110:3458\u201383.","journal-title":"Neuron"},{"key":"1797_CR6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/fphar.2019.00239","volume":"10","author":"P Malko","year":"2019","unstructured":"Malko P, Syed Mortadza SA, McWilliam J, Jiang L-H. TRPM2 channel in microglia as a new player in neuroinflammation associated with a spectrum of central nervous system pathologies. Front Pharmacol. 2019;10:239.","journal-title":"Front Pharmacol"},{"key":"1797_CR7","doi-asserted-by":"crossref","unstructured":"Maliougina M, El Hiani Y. TRPM2: bridging calcium and ROS signaling pathways\u2014implications for human diseases. Front Physiol. 2023;14:1217828.","DOI":"10.3389\/fphys.2023.1217828"},{"key":"1797_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1254\/jphs.FP0060128","volume":"101","author":"S Kaneko","year":"2006","unstructured":"Kaneko S, Kawakami S, Hara Y, Wakamori M, Itoh E, Minami T, et al. A critical role of TRPM2 in neuronal cell death by hydrogen peroxide. J Pharmacol Sci. 2006;101:66\u201376.","journal-title":"J Pharmacol Sci"},{"key":"1797_CR9","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1002\/glia.20547","volume":"55","author":"CE Bond","year":"2007","unstructured":"Bond CE, Greenfield SA. Multiple cascade effects of oxidative stress on astroglia. Glia. 2007;55:1348\u201361.","journal-title":"Glia"},{"key":"1797_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1152\/ajpcell.00331.2003","volume":"286","author":"R Kraft","year":"2004","unstructured":"Kraft R, Grimm C, Grosse K, Hoffmann A, Sauerbruch S, Kettenmann H, et al. Hydrogen peroxide and ADP-ribose induce TRPM2-mediated calcium influx and cation currents in microglia. Am J Physiol Cell Physiol. 2004;286:129\u201337.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1797_CR11","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1113\/JP279521","volume":"601","author":"K Pan","year":"2023","unstructured":"Pan K, Garaschuk O. The role of intracellular calcium-store-mediated calcium signals in in vivo sensor and effector functions of microglia. J Physiol. 2023;601:4203\u201315.","journal-title":"J Physiol"},{"key":"1797_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/224285a0","volume":"224","author":"DJ COSENS","year":"1969","unstructured":"Cosens DJ, Manning A. Abnormal electroretinogram from a Drosophila mutant. Nature. 1969;224:285\u20137.","journal-title":"Nature"},{"key":"1797_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S1097-2765(02)00448-3","volume":"9","author":"C Montell","year":"2002","unstructured":"Montell C, Birnbaumer L, Flockerzi V, Bindels RJ, Bruford EA, Caterina MJ, et al. A unified nomenclature for the superfamily of TRP cation channels. Mol Cell. 2002;9:229\u201331.","journal-title":"Mol Cell"},{"key":"1797_CR14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41392-023-01464-x","volume":"8","author":"M Zhang","year":"2023","unstructured":"Zhang M, Ma Y, Ye X, Zhang N, Pan L, Wang B. TRP (transient receptor potential) ion channel family: structures, biological functions and therapeutic interventions for diseases. Signal Transduct Target Ther. 2023;8:261.","journal-title":"Signal Transduct Target Ther"},{"key":"1797_CR15","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.tips.2004.10.004","volume":"25","author":"A Fleig","year":"2004","unstructured":"Fleig A, Penner R. The TRPM ion channel subfamily: molecular, biophysical and functional features. Trends Pharmacol Sci. 2004;25:633\u20139.","journal-title":"Trends Pharmacol Sci"},{"key":"1797_CR16","first-page":"1515","volume":"58","author":"LM Duncan","year":"1998","unstructured":"Duncan LM, Deeds J, Hunter J, Shao J, Holmgren LM, Woolf EA, et al. Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis. Cancer Res. 1998;58:1515\u201320.","journal-title":"Cancer Res"},{"key":"1797_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ceca.2019.102111","volume":"85","author":"Y Huang","year":"2020","unstructured":"Huang Y, Fliegert R, Guse AH, L\u00fc W, Du J. A structural overview of the ion channels of the TRPM family. Cell Calcium. 2020;85:1\u201325.","journal-title":"Cell Calcium"},{"key":"1797_CR18","doi-asserted-by":"crossref","unstructured":"Wang L, Fu T-M, Zhou Y, Xia S, Greka A, Wu H. Structures and gating mechanism of human TRPM2. Science. 2018;362:4809.","DOI":"10.1126\/science.aav4809"},{"key":"1797_CR19","doi-asserted-by":"crossref","unstructured":"Huang Y, Roth B, L\u00fc W, Du J. Ligand recognition and gating mechanism through three ligand-binding sites of human TRPM2 channel. Elife. 2019;8:e50175.","DOI":"10.7554\/eLife.50175"},{"key":"1797_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11733-5","volume":"10","author":"Y Yin","year":"2019","unstructured":"Yin Y, Wu M, Hsu AL, Borschel WF, Borgnia MJ, Lander GC, et al. Visualizing structural transitions of ligand-dependent gating of the TRPM2 channel. Nat Commun. 2019;10:3740.","journal-title":"Nat Commun"},{"key":"1797_CR21","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1111\/febs.12304","volume":"280","author":"C D\u00f6lle","year":"2013","unstructured":"D\u00f6lle C, Rack JGM, Ziegler M. NAD and ADP-ribose metabolism in mitochondria. FEBS J. 2013;280:3530\u201341.","journal-title":"FEBS J"},{"key":"1797_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S1097-2765(01)00438-5","volume":"9","author":"Y Hara","year":"2002","unstructured":"Hara Y, Wakamori M, Ishii M, Maeno E, Nishida M, Yoshida T, et al. LTRPC2 Ca2+-permeable channel activated by changes in redox status confers susceptibility to cell death. Mol Cell. 2002;9:163\u201373.","journal-title":"Mol Cell"},{"key":"1797_CR23","doi-asserted-by":"publisher","first-page":"6138","DOI":"10.1074\/jbc.M411446200","volume":"280","author":"A-L Perraud","year":"2005","unstructured":"Perraud A-L, Takanishi CL, Shen B, Kang S, Smith MK, Schmitz C, et al. Accumulation of free ADP-ribose from mitochondria mediates oxidative stress-induced gating of TRPM2 cation channels. J Biol Chem. 2005;280:6138\u201348.","journal-title":"J Biol Chem"},{"key":"1797_CR24","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1038\/sj.emboj.7601083","volume":"25","author":"K Togashi","year":"2006","unstructured":"Togashi K, Hara Y, Tominaga T, Higashi T, Konishi Y, Mori Y, et al. TRPM2 activation by cyclic ADP-ribose at body temperature is involved in insulin secretion. EMBO J. 2006;25:1804\u201315.","journal-title":"EMBO J"},{"key":"1797_CR25","doi-asserted-by":"crossref","unstructured":"Hecquet CM, Ahmmed GU, Malik AB. TRPM2 channel regulates endothelial barrier function. Adv Exp Med Biol. 2010: 661:155-67.","DOI":"10.1007\/978-1-60761-500-2_10"},{"key":"1797_CR26","doi-asserted-by":"publisher","first-page":"16222","DOI":"10.1074\/jbc.M300298200","volume":"278","author":"W Zhang","year":"2003","unstructured":"Zhang W, Chu X, Tong Q, Cheung JY, Conrad K, Masker K, et al. A novel TRPM2 isoform inhibits calcium influx and susceptibility to cell death. J Biol Chem. 2003;278:16222\u20139.","journal-title":"J Biol Chem"},{"key":"1797_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00424-005-1440-4","volume":"451","author":"S McNulty","year":"2005","unstructured":"McNulty S, Fonfria E. The role of TRPM channels in cell death. Pfl\u00fcgers Arch. 2005;451:235\u201342.","journal-title":"Pfl\u00fcgers Arch"},{"key":"1797_CR28","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/j.1471-4159.2005.03396.x","volume":"95","author":"E Fonfria","year":"2005","unstructured":"Fonfria E, Marshall ICB, Boyfield I, Skaper SD, Hughes JP, Owen DE, et al. Amyloid \u03b2-peptide(1\u201342) and hydrogen peroxide-induced toxicity are mediated by TRPM2 in rat primary striatal cultures. J Neurochem. 2005;95:715\u201323.","journal-title":"J Neurochem"},{"key":"1797_CR29","doi-asserted-by":"crossref","unstructured":"Ye M, Yang W, Ainscough JF, Hu XP, Li X, Sedo A, et al. TRPM2 channel deficiency prevents delayed cytosolic Zn2+ accumulation and CA1 pyramidal neuronal death after transient global ischemia. Cell Death Dis. 2014;5:e1541.","DOI":"10.1038\/cddis.2014.494"},{"key":"1797_CR30","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s12035-016-0338-9","volume":"55","author":"Y Sun","year":"2018","unstructured":"Sun Y, Sukumaran P, Selvaraj S, Cilz NI, Schaar A, Lei S, et al. TRPM2 promotes neurotoxin MPP+\/MPTP-induced cell death. Mol Neurobiol. 2018;55:409\u201320.","journal-title":"Mol Neurobiol"},{"key":"1797_CR31","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/aps.2018.31","volume":"39","author":"JC Belrose","year":"2018","unstructured":"Belrose JC, Jackson MF. TRPM2: a candidate therapeutic target for treating neurological diseases. Acta Pharmacol Sin. 2018;39:722\u201332.","journal-title":"Acta Pharmacol Sin"},{"key":"1797_CR32","first-page":"1","volume":"1","author":"J Steinman","year":"2022","unstructured":"Steinman J, Ovcjak A, Luo Z, Zhang X, Britto LR, Henderson JT, et al. Transient receptor potential melastatin 2 channels in neurological disorders: mechanisms and animal models. Adv Neurol. 2022;1:1\u201318.","journal-title":"Adv Neurol"},{"key":"1797_CR33","first-page":"0","volume":"18","author":"AF Ferreira","year":"2023","unstructured":"Ferreira AF, Britto LG. The transient receptor potential melastatin 2: a new therapeutical target for Parkinson\u2032s disease?\u00a0Neural Regen Res. 2023;18:1652-6.","journal-title":"Neural Regen Res"},{"key":"1797_CR34","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/nm1758","volume":"14","author":"S Yamamoto","year":"2008","unstructured":"Yamamoto S, Shimizu S, Kiyonaka S, Takahashi N, Wajima T, Hara Y, et al. TRPM2-mediated Ca2+ influx induces chemokine production in monocytes that aggravates inflammatory neutrophil infiltration. Nat Med. 2008;14:738\u201347.","journal-title":"Nat Med"},{"key":"1797_CR35","unstructured":"Virchow R. Gesammelte Abhandlungen Zur Wissenschaftlichen Medicin. (Frankfurt a. M: Meidinger, 1856)."},{"key":"1797_CR36","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1002\/glia.23046","volume":"64","author":"A Sierra","year":"2016","unstructured":"Sierra A, de Castro F, del R\u00edo-Hortega J, Rafael Iglesias-Rozas J, Garrosa M, Kettenmann H. The \u201cBig-Bang\u201d for modern glial biology: translation and comments on P\u00edo del R\u00edo-Hortega 1919 series of papers on microglia. Glia. 2016;64:1801\u201340.","journal-title":"Glia"},{"key":"1797_CR37","first-page":"255","volume":"11","author":"Y Ram\u00f3n","year":"1913","unstructured":"Ram\u00f3n Y, Cajal S. Contribuci\u00f3n al conocimiento de la neuroglia del cerebro humano. Trab Lab Invest Biol. 1913;11:255.","journal-title":"Trab Lab Invest Biol"},{"key":"1797_CR38","unstructured":"R\u00edo-Hortega P del. El\u201d Tercer\u201d\u201c Elemento\u201d de Los Centros Nerviosos: Poder Fagocitario y Movilidad de La Microglia. (1919)."},{"key":"1797_CR39","first-page":"108","volume":"8","author":"P R\u00edo-Hortega","year":"1919","unstructured":"R\u00edo-Hortega P. del. El \u201ctercer elemento\u201d de los centros nerviosos. III. Naturaleza Probable de la Microgl\u00eda Bol Soc Esp Biol. 1919;8:108\u201315.","journal-title":"Naturaleza Probable de la Microgl\u00eda Bol Soc Esp Biol"},{"key":"1797_CR40","first-page":"68","volume":"8","author":"P R\u00edo-Hortega","year":"1919","unstructured":"R\u00edo-Hortega P. del. El \u2018tercer elemento\u2019de los centros nerviosos. I La Microgl\u0131a en Estado Norm Bol Soc Esp Biol. 1919;8:68\u201392.","journal-title":"I La Microgl\u0131a en Estado Norm Bol Soc Esp Biol"},{"key":"1797_CR41","unstructured":"R\u00edo-Hortega P del. El \u2018Tercer Elemento de Los Centros Nerviosos\u2019. II. Intervenci\u00f3n de La Microgl\u00eda En Los Procesos Patol\u00f3gicos (C\u00e9lulas En Bastoncito y Cuerpos Gr\u00e1nuloadiposos), Bolet\u00edn de La Sociedad Espa\u00f1ola de Biolog\u00eda VIII. (Bol Soc Esp Biol. 1919)."},{"key":"1797_CR42","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.tins.2019.09.004","volume":"42","author":"A Sierra","year":"2019","unstructured":"Sierra A, Paolicelli RC, Kettenmann H. Cien A\u00f1os de Microgl\u00eda: milestones in a century of microglial research. Trends Neurosci. 2019;42:778\u201392.","journal-title":"Trends Neurosci"},{"key":"1797_CR43","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0896-6273(04)00069-8","volume":"41","author":"JL Mar\u0131\u0301n-Teva","year":"2004","unstructured":"Mar\u0131\u0301n-Teva JL, Dusart I, Colin C, Gervais A, van Rooijen N, Mallat M. Microglia promote the death of developing purkinje cells. Neuron. 2004;41:535\u201347.","journal-title":"Neuron"},{"key":"1797_CR44","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.stem.2010.08.014","volume":"7","author":"A Sierra","year":"2010","unstructured":"Sierra A, Encinas JM, Deudero JJP, Chancey JH, Enikolopov G, Overstreet-Wadiche LS, et al. Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. Cell Stem Cell. 2010;7:483\u201395.","journal-title":"Cell Stem Cell"},{"key":"1797_CR45","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1126\/science.1202529","volume":"333","author":"RC Paolicelli","year":"2011","unstructured":"Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, et al. Synaptic pruning by microglia is necessary for normal brain development. Science. 2011;333:1456\u20138.","journal-title":"Science"},{"key":"1797_CR46","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.cell.2013.11.030","volume":"155","author":"CN Parkhurst","year":"2013","unstructured":"Parkhurst CN, Yang G, Ninan I, Savas JN, Yates JR, Lafaille JJ, et al. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell. 2013;155:1596\u2013609.","journal-title":"Cell"},{"key":"1797_CR47","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/0006-8993(89)90078-4","volume":"491","author":"M Sawada","year":"1989","unstructured":"Sawada M, Kondo N, Suzumura A, Marunouchi T. Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res. 1989;491:394\u20137.","journal-title":"Brain Res"},{"key":"1797_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02309-6","volume":"18","author":"SC Woodburn","year":"2021","unstructured":"Woodburn SC, Bollinger JL, Wohleb ES. The semantics of microglia activation: neuroinflammation, homeostasis, and stress. J Neuroinflamm. 2021;18:258.","journal-title":"J Neuroinflamm"},{"key":"1797_CR49","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/cns.13899","volume":"28","author":"F Yu","year":"2022","unstructured":"Yu F, Wang Y, Stetler AR, Leak RK, Hu X, Chen J. Phagocytic microglia and macrophages in brain injury and repair. CNS Neurosci Ther. 2022;28:1279\u201393.","journal-title":"CNS Neurosci Ther"},{"key":"1797_CR50","first-page":"227","volume":"25","author":"MK Jha","year":"2019","unstructured":"Jha MK, Jo M, Kim JH, Suk K. Microglia-astrocyte crosstalk: an intimate molecular conversation. Neuroscience. 2019;25:227\u201340.","journal-title":"Neurosci"},{"key":"1797_CR51","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.semcdb.2019.05.017","volume":"94","author":"S Marinelli","year":"2019","unstructured":"Marinelli S, Basilico B, Marrone MC, Ragozzino D. Microglia-neuron crosstalk: signaling mechanism and control of synaptic transmission. Semin Cell Dev Biol. 2019;94:138\u201351.","journal-title":"Semin Cell Dev Biol"},{"key":"1797_CR52","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352:712\u20136.","journal-title":"Science"},{"key":"1797_CR53","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41593-021-00951-0","volume":"25","author":"P d\u2019Errico","year":"2022","unstructured":"d\u2019Errico P, Ziegler-Waldkirch S, Aires V, Hoffmann P, Mez\u00f6 C, Erny D, et al. Microglia contribute to the propagation of A\u03b2 into unaffected brain tissue. Nat Neurosci. 2022;25:20\u20135.","journal-title":"Nat Neurosci"},{"key":"1797_CR54","doi-asserted-by":"crossref","unstructured":"Lai TT, Kim YJE, Nguyen LTN, Nguyen TT, Kwak IH, Richter F, et al. Microglial inhibition alleviates Alpha-Synuclein propagation and neurodegeneration in Parkinson\u2019s disease mouse model. npj Park Dis. 2024;10:32.","DOI":"10.1038\/s41531-024-00640-2"},{"key":"1797_CR55","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1146\/annurev-physiol-022516-034406","volume":"79","author":"SA Wolf","year":"2017","unstructured":"Wolf SA, Boddeke HWGM, Kettenmann H. Microglia in physiology and disease. Annu Rev Physiol. 2017;79:619\u201343.","journal-title":"Annu Rev Physiol"},{"key":"1797_CR56","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","volume":"8","author":"C Gao","year":"2023","unstructured":"Gao C, Jiang J, Tan Y, Chen S. Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Target Ther. 2023;8:359.","journal-title":"Signal Transduct Target Ther"},{"key":"1797_CR57","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1152\/physrev.00011.2010","volume":"91","author":"H Kettenmann","year":"2011","unstructured":"Kettenmann H, Hanisch U-K, Noda M, Verkhratsky A. Physiology of microglia. Physiol Rev. 2011;91:461\u2013553.","journal-title":"Physiol Rev"},{"key":"1797_CR58","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1136\/svn-2016-000012","volume":"1","author":"H Liu","year":"2016","unstructured":"Liu H, Leak RK, Hu X. Neurotransmitter receptors on microglia. Stroke Vasc Neurol. 2016;1:52\u20138.","journal-title":"Stroke Vasc Neurol"},{"key":"1797_CR59","doi-asserted-by":"crossref","unstructured":"Fu J, Wang R, He J, Liu X, Wang X, Yao J, et al. Pathogenesis and therapeutic applications of microglia receptors in Alzheimer\u2019s disease. Front Immunol. 2025;16:1508023.","DOI":"10.3389\/fimmu.2025.1508023"},{"key":"1797_CR60","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4161\/chan.3.2.8609","volume":"3","author":"L Ohana","year":"2009","unstructured":"Ohana L, Newell EW, Stanley EF, Schlichter LC. The Ca2+ release-activated Ca2+ current (I CRAC) mediates store-operated Ca2+ entry in rat microglia. Channels. 2009;3:129\u201339.","journal-title":"Channels"},{"key":"1797_CR61","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/10799890600637522","volume":"26","author":"E Fonfria","year":"2006","unstructured":"Fonfria E, Mattei C, Hill K, Brown JT, Randall A, Benham CD, et al. TRPM2 is elevated in the tMCAO stroke model, transcriptionally regulated, and functionally expressed in C13 microglia. J Recept Signal Transduct. 2006;26:179\u201398.","journal-title":"J Recept Signal Transduct"},{"key":"1797_CR62","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1096\/fj.09-149997","volume":"24","author":"M Lee","year":"2010","unstructured":"Lee M, Cho T, Jantaratnotai N, Wang YT, McGeer E, McGeer PL. Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases. FASEB J. 2010;24:2533\u201345.","journal-title":"FASEB J"},{"key":"1797_CR63","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bbrc.2014.01.022","volume":"444","author":"T Miyake","year":"2014","unstructured":"Miyake T, Shirakawa H, Kusano A, Sakimoto S, Konno M, Nakagawa T, et al. TRPM2 contributes to LPS\/IFN\u03b3-induced production of nitric oxide via the p38\/JNK pathway in microglia. Biochem Biophys Res Commun. 2014;444:212\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"1797_CR64","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40360-024-00779-x","volume":"25","author":"K Kasuya","year":"2024","unstructured":"Kasuya K, Takahashi K, Hashimoto M, Ohta T. Nociceptive transient receptor potential ankyrin 1 (TRPA1) in sensory neurons are targets of the antifungal drug econazole. BMC Pharmacol Toxicol. 2024;25:53.","journal-title":"BMC Pharmacol Toxicol"},{"key":"1797_CR65","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.bbrc.2017.02.087","volume":"485","author":"H Jeong","year":"2017","unstructured":"Jeong H, Kim YH, Lee Y, Jung SJ, Oh SB. TRPM2 contributes to LPC-induced intracellular Ca2+ influx and microglial activation. Biochem Biophys Res Commun. 2017;485:301\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"1797_CR66","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1126\/science.273.5276.792","volume":"273","author":"G Tokiwa","year":"1996","unstructured":"Tokiwa G, Dikic I, Lev S, Schlessinger J. Activation of Pyk2 by stress signals and coupling with JNK signaling pathway. Science. 1996;273:792\u20134.","journal-title":"Science"},{"key":"1797_CR67","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1093\/emboj\/18.9.2480","volume":"18","author":"A Takaoka","year":"1999","unstructured":"Takaoka A, Tanaka N, Mitani Y, Miyazaki T, Fujii H, Sato M, et al. Protein tyrosine kinase Pyk2 mediates the JAK-dependent activation of MAPK and Stat1 in IFN-gamma, but not IFN-alpha, signaling. EMBO J. 1999;18:2480\u20138.","journal-title":"EMBO J"},{"key":"1797_CR68","doi-asserted-by":"crossref","unstructured":"Soares-Silva M, Diniz FF, Gomes GN, Bahia D. The mitogen-activated protein kinase (MAPK) pathway: role in immune evasion by trypanosomatids. Front Microbiol. 2016;7:183.","DOI":"10.3389\/fmicb.2016.00183"},{"key":"1797_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep45032","volume":"7","author":"SS Mortadza","year":"2017","unstructured":"Mortadza SS, Sim JA, Stacey M, Jiang LHH. Signalling mechanisms mediating Zn2+-induced TRPM2 channel activation and cell death in microglial cells. Sci Rep. 2017;7:1\u201315.","journal-title":"Sci Rep"},{"key":"1797_CR70","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/glia.23265","volume":"66","author":"S Alawieyah Syed Mortadza","year":"2018","unstructured":"Alawieyah Syed Mortadza S, Sim JA, Neubrand VE, Jiang LH. A critical role of TRPM2 channel in A\u03b242-induced microglial activation and generation of tumor necrosis factor-\u03b1. Glia. 2018;66:562\u201375.","journal-title":"Glia"},{"key":"1797_CR71","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1016\/S0140-6736(24)00642-1","volume":"403","author":"NA Hilkens","year":"2024","unstructured":"Hilkens NA, Casolla B, Leung TW. de Leeuw FE. Stroke. Lancet. 2024;403:2820\u201336.","journal-title":"Lancet"},{"key":"1797_CR72","unstructured":"Lui F, Khan Suheb M, Patti L. Ischemic Stroke. (StatPearls Publishing, 2025)."},{"key":"1797_CR73","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/med.21817","volume":"42","author":"Q Tuo","year":"2022","unstructured":"Tuo Q, Zhang S, Lei P. Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications. Med Res Rev. 2022;42:259\u2013305.","journal-title":"Med Res Rev"},{"key":"1797_CR74","first-page":"1165","volume":"47","author":"SF De Meyer","year":"2016","unstructured":"De Meyer SF, Denorme F, Langhauser F, Geuss E, Fluri F, Kleinschnitz C. Thromboinflammation in. Stroke Brain Damage Stroke. 2016;47:1165\u201372.","journal-title":"Stroke Brain Damage Stroke"},{"key":"1797_CR75","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.1007\/s12035-015-9418-5","volume":"53","author":"M-H Wu","year":"2016","unstructured":"Wu MH, Huang CC, Chio CC, Tsai KJ, Chang CP, Lin NK, et al. Inhibition of peripheral TNF-\u03b1 and downregulation of microglial activation by alpha-lipoic acid and etanercept protect rat brain against ischemic stroke. Mol Neurobiol. 2016;53:4961\u201371.","journal-title":"Mol Neurobiol"},{"key":"1797_CR76","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1016\/j.neuron.2022.03.021","volume":"110","author":"P Zong","year":"2022","unstructured":"Zong P, Feng J, Yue Z, Li Y, Wu G, Sun B, et al. Functional coupling of TRPM2 and extrasynaptic NMDARs exacerbates excitotoxicity in ischemic brain injury. Neuron. 2022;110:1944\u20131958.e8.","journal-title":"Neuron"},{"key":"1797_CR77","doi-asserted-by":"publisher","first-page":"17264","DOI":"10.1523\/JNEUROSCI.1729-13.2013","volume":"33","author":"I Alim","year":"2013","unstructured":"Alim I, Teves L, Li R, Mori Y, Tymianski M. Modulation of NMDAR subunit expression by TRPM2 channels regulates neuronal vulnerability to ischemic cell death. J Neurosci. 2013;33:17264\u201377.","journal-title":"J Neurosci"},{"key":"1797_CR78","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.expneurol.2016.06.015","volume":"283","author":"T Shimizu","year":"2016","unstructured":"Shimizu T, Dietz RM, Cruz-Torres I, Strnad F, Garske AK, Moreno M, et al. Extended therapeutic window of a novel peptide inhibitor of TRPM2 channels following focal cerebral ischemia. Exp Neurol. 2016;283:151\u20136.","journal-title":"Exp Neurol"},{"key":"1797_CR79","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/jcbfm.2013.105","volume":"33","author":"T Shimizu","year":"2013","unstructured":"Shimizu T, MacEy TA, Quillinan N, Klawitter J, Perraud ALL, Traystman RJ, et al. Androgen and PARP-1 regulation of TRPM2 channels after ischemic injury. J Cereb Blood Flow Metab. 2013;33:1549\u201355.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1797_CR80","doi-asserted-by":"publisher","first-page":"8109","DOI":"10.1007\/s12035-019-01656-z","volume":"56","author":"F Li","year":"2019","unstructured":"Li F, Wong R, Luo Z, Du L, Turlova E, Britto LRG, et al. Neuroprotective effects of AG490 in neonatal hypoxic-ischemic brain injury. Mol Neurobiol. 2019;56:8109\u201323.","journal-title":"Mol Neurobiol"},{"key":"1797_CR81","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.expneurol.2017.06.023","volume":"296","author":"S Huang","year":"2017","unstructured":"Huang S, Turlova E, Li F. Bao M hua, Szeto V, Wong R, et al. Transient receptor potential melastatin 2 channels (TRPM2) mediate neonatal hypoxic-ischemic brain injury in mice. Exp Neurol. 2017;296:32\u201340.","journal-title":"Exp Neurol"},{"key":"1797_CR82","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1523\/JNEUROSCI.2451-17.2018","volume":"38","author":"J Miyanohara","year":"2018","unstructured":"Miyanohara J, Kakae M, Nagayasu K, Nakagawa T, Mori Y, Arai K, et al. TRPM2 channel aggravates CNS inflammation and cognitive impairment via activation of microglia in chronic cerebral hypoperfusion. J Neurosci. 2018;38:3520\u201333.","journal-title":"J Neurosci"},{"key":"1797_CR83","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman DS, Amieva H, Petersen RC, Ch\u00e9telat G, Holtzman DM, Hyman BT, et al. Alzheimer disease. Nat Rev Dis Prim. 2021;7:33.","journal-title":"Nat Rev Dis Prim"},{"key":"1797_CR84","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/ca.980080612","volume":"8","author":"RA Stelzmann","year":"1995","unstructured":"Stelzmann RA, Norman Schnitzlein H, Reed Murtagh F. An english translation of alzheimer\u2019s 1907 paper, \u201c\u00fcber eine eigenartige erkankung der hirnrinde\u201d. Clin Anat. 1995;8:429\u201331.","journal-title":"Clin Anat"},{"key":"1797_CR85","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1016\/j.neurobiolaging.2014.03.026","volume":"35","author":"CE Hanzel","year":"2014","unstructured":"Hanzel CE, Pichet-Binette A, Pimentel LSB, Iulita MF, Allard S, Ducatenzeiler A, et al. Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer\u2019s disease. Neurobiol Aging. 2014;35:2249\u201362.","journal-title":"Neurobiol Aging"},{"key":"1797_CR86","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41590-021-00913-5","volume":"22","author":"Y Huang","year":"2021","unstructured":"Huang Y, Happonen KE, Burrola PG, O\u2019Connor C, Hah N, Huang L, et al. Microglia use TAM receptors to detect and engulf amyloid \u03b2 plaques. Nat Immunol. 2021;22:586\u201394.","journal-title":"Nat Immunol"},{"key":"1797_CR87","doi-asserted-by":"publisher","first-page":"115052","DOI":"10.1016\/j.celrep.2024.115052","volume":"43","author":"RG Jacquet","year":"2024","unstructured":"Jacquet RG, Gonz\u00e1lez Ib\u00e1\u00f1ez F, Picard K, Funes L, Khakpour M, Gouras GK, et al. Microglia degrade Alzheimer\u2019s amyloid-beta deposits extracellularly via digestive exophagy. Cell Rep. 2024;43:115052.","journal-title":"Cell Rep"},{"key":"1797_CR88","doi-asserted-by":"publisher","first-page":"15157","DOI":"10.1523\/JNEUROSCI.4081-14.2015","volume":"35","author":"VG Ostapchenko","year":"2015","unstructured":"Ostapchenko VG, Chen M, Guzman MS, Xie YF, Lavine N, Fan J, et al. The transient receptor potential melastatin 2 (TRPM2) channel contributes to \u03b2-amyloid oligomer-related neurotoxicity and memory impairment. J Neurosci. 2015;35:15157\u201369.","journal-title":"J Neurosci"},{"key":"1797_CR89","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.neulet.2013.10.051","volume":"557","author":"K Lok","year":"2013","unstructured":"Lok K, Zhao H, Shen H, Wang Z, Gao X, Zhao W, et al. Characterization of the APP\/PS1 mouse model of Alzheimer\u2019s disease in senescence accelerated background. Neurosci Lett. 2013;557:84\u20139.","journal-title":"Neurosci Lett"},{"key":"1797_CR90","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1002\/cne.24555","volume":"527","author":"JD Whitesell","year":"2019","unstructured":"Whitesell JD, Buckley AR, Knox JE, Kuan L, Graddis N, Pelos A, et al. Whole brain imaging reveals distinct spatial patterns of amyloid beta deposition in three mouse models of Alzheimer\u2019s disease. J Comp Neurol. 2019;527:2122\u201345.","journal-title":"J Comp Neurol"},{"key":"1797_CR91","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.14108","volume":"27","author":"R Balestrino","year":"2020","unstructured":"Balestrino R, Schapira AHV. Parkinson disease. Eur J Neurol. 2020;27:27\u201342.","journal-title":"Eur J Neurol"},{"key":"1797_CR92","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris HR, Spillantini MG, Sue CM, Williams-Gray CH. The pathogenesis of Parkinson\u2019s disease. Lancet. 2024;403:293\u2013304.","journal-title":"Lancet"},{"key":"1797_CR93","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology. 1988;38:1285\u201391.","journal-title":"Neurology"},{"key":"1797_CR94","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","volume":"21","author":"A Gerhard","year":"2006","unstructured":"Gerhard A, Pavese N, Hotton G, Turkheimer F, Es M, Hammers A, et al. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson\u2019s disease. Neurobiol Dis. 2006;21:404\u201312.","journal-title":"Neurobiol Dis"},{"key":"1797_CR95","doi-asserted-by":"crossref","unstructured":"Janda E, Boi L, Carta AR. Microglial phagocytosis and its regulation: a therapeutic target in Parkinson\u2019s disease? Front Mol Neurosci. 2018;11:144.","DOI":"10.3389\/fnmol.2018.00144"},{"key":"1797_CR96","doi-asserted-by":"crossref","unstructured":"Schr\u00f6der JB, Pawlowski M, Meyer zu H\u00f6rste G, Gross CC, Wiendl H, Meuth SG, et al. Immune cell activation in the cerebrospinal fluid of patients with Parkinson\u2019s disease. Front Neurol. 2018;9:1081.","DOI":"10.3389\/fneur.2018.01081"},{"key":"1797_CR97","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s12035-022-02723-8","volume":"59","author":"AFF Ferreira","year":"2022","unstructured":"Ferreira AFF, Singulani MP, Ulrich H, Feng ZP, Sun HS, Britto LR. Inhibition of TRPM2 by AG490 is neuroprotective in a Parkinson\u2019s disease animal model. Mol Neurobiol. 2022;59:1543\u201359.","journal-title":"Mol Neurobiol"},{"key":"1797_CR98","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.neuro.2022.03.010","volume":"90","author":"H Tamura","year":"2022","unstructured":"Tamura H, Nishio R, Saeki N, Katahira M, Morioka H, Tamano H, et al. Paraquat-induced intracellular Zn2+ dysregulation causes dopaminergic degeneration in the substantia nigra, but not in the striatum. Neurotoxicology. 2022;90:136\u201344.","journal-title":"Neurotoxicology"},{"key":"1797_CR99","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1007\/s12035-021-02711-4","volume":"59","author":"B Vaidya","year":"2022","unstructured":"Vaidya B, Kaur H, Thapak P, Sharma SS, Singh JN. Pharmacological modulation of TRPM2 channels via PARP pathway leads to neuroprotection in MPTP-induced Parkinson\u2019s disease in Sprague Dawley rats. Mol Neurobiol. 2022;59:1528\u201342.","journal-title":"Mol Neurobiol"},{"key":"1797_CR100","doi-asserted-by":"crossref","unstructured":"Ye P, Fang Q, Hu X, Zou W, Huang M, Ke M, et al. TRPM2 as a conserved gatekeeper determines the vulnerability of DA neurons by mediating ROS sensing and calcium dyshomeostasis. Prog Neurobiol. 2023; 231:102530.","DOI":"10.1016\/j.pneurobio.2023.102530"},{"key":"1797_CR101","doi-asserted-by":"publisher","unstructured":"Ferreira AFF, Ulrich H, Mori Y, Feng Z-P, Sun H-S, Britto LR. Deletion of the transient receptor potential Melastatin 2 gene mitigates the 6-Hydroxydopamine-Induced Parkinson\u2019s disease\u2013like pathology. Mol Neurobiol. 2024; https:\/\/doi.org\/10.1007\/s12035-024-04611-9.","DOI":"10.1007\/s12035-024-04611-9"},{"key":"1797_CR102","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.1007\/s12035-020-01974-7","volume":"57","author":"K Y\u0131ld\u0131zhan","year":"2020","unstructured":"Y\u0131ld\u0131zhan K, Naz\u0131ro\u011flu M. Glutathione depletion and Parkinsonian neurotoxin MPP+-induced TRPM2 channel activation play central roles in oxidative cytotoxicity and inflammation in microglia. Mol Neurobiol. 2020;57:3508\u201325.","journal-title":"Mol Neurobiol"},{"key":"1797_CR103","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ejphar.2014.08.023","volume":"742","author":"S Shimizu","year":"2014","unstructured":"Shimizu S, Yonezawa R, Hagiwara T, Yoshida T, Takahashi N, Hamano S, et al. Inhibitory effects of AG490 on H2O2-induced TRPM2-mediated Ca2+\u00a0entry. Eur J Pharmacol. 2014;742:22\u201330.","journal-title":"Eur J Pharmacol"},{"key":"1797_CR104","doi-asserted-by":"crossref","unstructured":"Jurga AM, Paleczna M, Kuter KZ. Overview of general and discriminating markers of differential microglia phenotypes. Front Cell Neurosci. 2020;14:198.","DOI":"10.3389\/fncel.2020.00198"},{"key":"1797_CR105","doi-asserted-by":"publisher","first-page":"724","DOI":"10.4103\/1673-5374.266917","volume":"15","author":"Y-F Zhu","year":"2020","unstructured":"Zhu YF, Wang WP, Zheng XF, Chen Z, Chen T, Huang ZY, et al. Characteristic response of striatal astrocytes to dopamine depletion. Neural Regen Res. 2020;15:724.","journal-title":"Neural Regen Res"},{"key":"1797_CR106","doi-asserted-by":"publisher","first-page":"114780","DOI":"10.1016\/j.expneurol.2024.114780","volume":"377","author":"AFF Ferreira","year":"2024","unstructured":"Ferreira AFF, Ulrich H, Feng ZP, Sun HS, Britto LR. Neurodegeneration and glial morphological changes are both prevented by TRPM2 inhibition during the progression of a Parkinson\u2019s disease mouse model. Exp Neurol. 2024;377:114780.","journal-title":"Exp Neurol"},{"key":"1797_CR107","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Arjona M del M, Grondona JM, Fern\u00e1ndez-Llebrez P, L\u00f3pez-\u00c1valos MD. Microglial morphometric parameters correlate with the expression level of IL-1\u03b2, and allow identifying different activated morphotypes. Front. Cell. Neurosci. 2019;13:472.","DOI":"10.3389\/fncel.2019.00472"},{"key":"1797_CR108","doi-asserted-by":"crossref","unstructured":"Ferreira AFF, Feng Z, Sun H, Britto LRG. Microglial activation and inflammatory responses in Parkinson\u2019s disease models are attenuated by TRPM2 depletion. Glia. 2025;73:2035-56.","DOI":"10.1002\/glia.70055"},{"key":"1797_CR109","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1097\/j.pain.0000000000001939","volume":"161","author":"SN Raja","year":"2020","unstructured":"Raja SN, Carr DB, Cohen M, Finnerup NB, Flor H, Gibson S, et al. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain. 2020;161:1976\u201382.","journal-title":"Pain"},{"key":"1797_CR110","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neurol.2018.09.016","volume":"175","author":"D Bouhassira","year":"2019","unstructured":"Bouhassira D. Neuropathic pain: definition, assessment and epidemiology. Rev Neurol. 2019;175:16\u201325.","journal-title":"Rev Neurol"},{"key":"1797_CR111","doi-asserted-by":"publisher","first-page":"17002","DOI":"10.1038\/nrdp.2017.2","volume":"3","author":"L Colloca","year":"2017","unstructured":"Colloca L, Ludman T, Bouhassira D, Baron R, Dickenson AH, Yarnitsky D, et al. Neuropathic pain. Nat Rev Dis Prim. 2017;3:17002.","journal-title":"Nat Rev Dis Prim"},{"key":"1797_CR112","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.tins.2023.05.001","volume":"46","author":"M Tsuda","year":"2023","unstructured":"Tsuda M, Masuda T, Kohno K. Microglial diversity in neuropathic pain. Trends Neurosci. 2023;46:597\u2013610.","journal-title":"Trends Neurosci"},{"key":"1797_CR113","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1523\/JNEUROSCI.4703-11.2012","volume":"32","author":"K Haraguchi","year":"2012","unstructured":"Haraguchi K, Kawamoto A, Isami K, Maeda S, Kusano A, Asakura K, et al. TRPM2 contributes to inflammatory and neuropathic pain through the aggravation of pronociceptive inflammatory responses in mice. J Neurosci. 2012;32:3931\u201341.","journal-title":"J Neurosci"},{"key":"1797_CR114","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.bbrc.2023.06.009","volume":"671","author":"C Yoshikawa","year":"2023","unstructured":"Yoshikawa C, Maegawa H, Usami N, Hanamoto H, Kudo C, Niwa H. Antagonist of transient receptor potential melastatin 2 suppresses mechanical hypersensitivity and activation of microglia induced by infraorbital nerve ligation in male rats. Biochem Biophys Res Commun. 2023;671:67\u201374.","journal-title":"Biochem Biophys Res Commun"},{"key":"1797_CR115","doi-asserted-by":"crossref","unstructured":"Xu H, Lu H, Lu L, Li Z, Piao Z, Jia Y, et al. Nanoparticulate MgH 2 suppresses TRPM2-mediated NLRP3 inflammasome to relieve bone cancer pain. Mol Pain. 2025;1:17448069251348770.","DOI":"10.1177\/17448069251348770"},{"key":"1797_CR116","unstructured":"World Health Organization. Epilepsy: a public health imperative. (WHO, 2019)."},{"key":"1797_CR117","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/j.0013-9580.2005.66104.x","volume":"46","author":"RS Fisher","year":"2005","unstructured":"Fisher RS, Boas W, van E, Blume W, Elger C, Genton P, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005;46:470\u20132.","journal-title":"Epilepsia"},{"key":"1797_CR118","doi-asserted-by":"crossref","unstructured":"Manole AM, Sirbu CA, Mititelu MR, Vasiliu O, Lorusso L, Sirbu OM, et al. State of the art and challenges in epilepsy-a narrative review. J Pers Med. 2023;13:623.","DOI":"10.3390\/jpm13040623"},{"key":"1797_CR119","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nn.3947","volume":"18","author":"K Staley","year":"2015","unstructured":"Staley K. Molecular mechanisms of epilepsy. Nat Neurosci. 2015;18:367\u201372.","journal-title":"Nat Neurosci"},{"key":"1797_CR120","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/glia.23006","volume":"65","author":"UB Eyo","year":"2017","unstructured":"Eyo UB, Murugan M, Wu L. Microglia\u2013neuron communication in epilepsy. Glia. 2017;65:5\u201318.","journal-title":"Glia"},{"key":"1797_CR121","doi-asserted-by":"publisher","first-page":"147","DOI":"10.5625\/lar.2018.34.4.147","volume":"34","author":"H Kim","year":"2018","unstructured":"Kim H, Kim M, Im SK, Fang S. Mouse Cre-LoxP system: general principles to determine tissue-specific roles of target genes. Lab Anim Res. 2018;34:147.","journal-title":"Lab Anim Res"},{"key":"1797_CR122","doi-asserted-by":"publisher","first-page":"106273","DOI":"10.1016\/j.nbd.2023.106273","volume":"186","author":"C Chen","year":"2023","unstructured":"Chen C, Zhu T, Gong L, Hu Z, Wei H, Fan J, et al. Trpm2 deficiency in microglia attenuates neuroinflammation during epileptogensis by upregulating autophagy via the AMPK\/mTOR pathway. Neurobiol Dis. 2023;186:106273.","journal-title":"Neurobiol Dis"},{"key":"1797_CR123","doi-asserted-by":"publisher","first-page":"e70271","DOI":"10.1002\/mco2.70271","volume":"6","author":"Y Xu","year":"2025","unstructured":"Xu Y, Ye L, Li Z, Zhang Y, Hua N, Wang X, et al. Microglial transient receptor potential melastatin 2 deficiency accelerates seizure development via increasing AMPAR-mediated neuronal excitability. MedComm. 2025;6:e70271.","journal-title":"MedComm"},{"key":"1797_CR124","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1021\/acs.jmedchem.0c02129","volume":"64","author":"H Zhang","year":"2021","unstructured":"Zhang H, Yu P, Lin H, Jin Z, Zhao S, Zhang Y, et al. The discovery of novel ACA derivatives as specific TRPM2 inhibitors that reduce ischemic injury both in vitro and in vivo. J Med Chem. 2021;64:3976\u201396.","journal-title":"J Med Chem"},{"key":"1797_CR125","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1016\/j.drudis.2020.09.039","volume":"25","author":"H Zhang","year":"2020","unstructured":"Zhang H, Zhao S, Yu J, Yang W, Liu Z, Zhang L. Medicinal chemistry perspective of TRPM2 channel inhibitors: where we are and where we might be heading? Drug Discov Today. 2020;25:2326\u201334.","journal-title":"Drug Discov Today"},{"key":"1797_CR126","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ejphar.2019.03.043","volume":"853","author":"L Fourgeaud","year":"2019","unstructured":"Fourgeaud L, Dvorak C, Faouzi M, Starkus J, Sahdeo S, Wang Q, et al. Pharmacology of JNJ-28583113: a novel TRPM2 antagonist. Eur J Pharmacol. 2019;853:299\u2013307.","journal-title":"Eur J Pharmacol"},{"key":"1797_CR127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.redox.2015.11.001","volume":"7","author":"E Kheradpezhouh","year":"2016","unstructured":"Kheradpezhouh E, Barritt GJ, Rychkov GY. Curcumin inhibits activation of TRPM2 channels in rat hepatocytes. Redox Biol. 2016;7:1\u20137.","journal-title":"Redox Biol"},{"key":"1797_CR128","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1021\/acs.jmedchem.6b00975","volume":"60","author":"KM Nelson","year":"2017","unstructured":"Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, Walters MA. The essential medicinal chemistry of curcumin. J Med Chem. 2017;60:1620\u201337.","journal-title":"J Med Chem"},{"key":"1797_CR129","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12031-013-0005-9","volume":"51","author":"S Nakayama","year":"2013","unstructured":"Nakayama S, Vest R, Traystman RJ, Herson PS. Sexually dimorphic response of TRPM2 inhibition following cardiac arrest-induced global cerebral ischemia in mice. J Mol Neurosci. 2013;51:92\u20138.","journal-title":"J Mol Neurosci"},{"key":"1797_CR130","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.expneurol.2015.10.014","volume":"275","author":"K Shimizu","year":"2016","unstructured":"Shimizu K, Quillinan N, Orfila JE, Herson PS. Sirtuin-2 mediates male specific neuronal injury following experimental cardiac arrest through activation of TRPM2 ion channels. Exp Neurol. 2016;275:78\u201383.","journal-title":"Exp Neurol"},{"key":"1797_CR131","doi-asserted-by":"publisher","first-page":"18029","DOI":"10.1073\/pnas.0808218105","volume":"105","author":"MC Hermosura","year":"2008","unstructured":"Hermosura MC, Cui AM, Go RCV, Davenport B, Shetler CM, Heizer JW, et al. Altered functional properties of a TRPM2 variant in Guamanian ALS and PD. Proc Natl Acad Sci USA. 2008;105:18029\u201334.","journal-title":"Proc Natl Acad Sci"},{"key":"1797_CR132","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jbiotec.2024.02.017","volume":"385","author":"\u00c1V T\u00f3th","year":"2024","unstructured":"T\u00f3th \u00c1V, Bart\u00f3k \u00c1. Reviewing critical TRPM2 variants through a structure-function lens. J Biotechnol. 2024;385:49\u201357.","journal-title":"J Biotechnol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01797-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01797-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01797-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T01:02:16Z","timestamp":1776906136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01797-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":132,"alternative-id":["1797"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01797-7","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author Hong-Shuo Sun is a member of the Editorial Board of the journal Acta Pharmacologica Sinica, but he has not been involved in the peer-review or decision-making process for this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}